meaningful use, mu audits and stage 2 measures – “is it worth the money?” chris apgar, cissp...

33
Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Upload: gerald-wood

Post on 23-Dec-2015

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Meaningful Use, MU Audits

and Stage 2 Measures – “Is

it Worth the Money?”Chris Apgar, CISSP

OrHIMA Fall Instutute 2014

Page 2: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Overview

Meaningful Use Overview

Who is Being Audited

Consequences of Failing an Audit

Preparing for and Surviving an Audit

Summary and Q&A

3

Page 3: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Meaningful Use

The purpose of Meaningful Use was to incentivize adoption of EHR technology

Hospitals and eligible health care professionals (EP) could apply for Medicare or Medicaid incentives

In some cases hospitals can apply for Medicaid and Medicare incentives

In most cases the amount of incentive dollars does not cover all expenses

3

Page 4: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Meaningful Use

EHR implementation and Meaningful Use attestation could be expensiveSoftware and hardware costsStaff trainingData conversionAdditional data collectionOngoing maintenance costs Increasing requirements of Stage 2

4

Page 5: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Meaningful Use

Stage 1 and Stage 2 Meaningful Use required hospitals and EPs to attest to having met a set number of core measures and a set number of measures from a list of additional measures

At the time of attestation, hospitals and EPs needed to be able to demonstrate measures were met if asked to prove it

5

Page 6: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Meaningful Use

May be able to delay move to MU Stage 2 and attest to Stage 1 instead

If you attested early, you may be stuck with Stage 2

Example: If you attested to MU in 2012, you must attest to Stage 2 in 2014. If you attested to MU in 2013, you can attest to Stage 1 in 2014.

6

Page 7: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Who’s Being Audited?

Per CMS if you attested, there’s a 10% chance you will be audited at some point

Audits are provider by provider versus by clinic or hospital

It doesn’t matter the size of the provider

You may be audited more than once7

Page 8: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

If You’re Audited…

Short time frame to respond

Documentation must definitively prove you met measures attested to

Documentation needs to be complete, easily accessible and very “black and white”

You may go through multiple rounds of documentation production

Document production requests not necessarily clear

8

Page 9: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

If You’re Audited…

If you’re unsure, ask before sending

Only provide what is asked for

Assign a point person to respond to attestation audits

Make sure your vendor can support providing needed documentation that is accurate

If non-compliant with HIPAA, auditor may report to OCR

9

Page 10: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

If You’re Audited…

You may fail the audit the first time – request clarification as to why

Make sure the auditor is specific – saves time in supplying multiple versions of documentation that may not be consistent

Keep all audit related documentation and communication with the auditor handy

10

Page 11: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Consequences if You Fail

If you ultimately fail an audit, expect a demand letter to repay Meaningful Use incentive dollars

If you receive a demand letter, you can appeal

For more information from CMS - https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Appeals.html 11

Page 12: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Consequences if You Fail

You do not have multiple levels of appeal

Failure to pay will likely result in withheld Medicare reimbursement

Audits go back to the first year of attestation – you may be audited for more than one period so may fail an audit for more than one period

No word on Oregon Medicaid audits yet

12

Page 13: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

How to Prepare

Understand all MU Requirements

Have a Clear Documentation Trail and create it before you attest

You will only have two weeks to respond – don’t start building your documentation trail when you receive the letter

13

Page 14: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

The Notice Arrives…

First Notice – two options to respond:Secure Web PortalMail

Check your documentation before you send it

Again, ask questions if you don’t understand what’s being requested

14

Page 15: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Documentation

Screen shots

Exact dates to match your attestation period

Audit Trail Documentation

EHR generated reports Make sure they work Make sure the data generated during the

attestation period is preserved

Sample discharge summaries, post-appointment documentation, etc.

15

Page 16: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

(A)Item

Number

Follow Up Request Date

Method Of Request

Follow Up Request Received

Date

Final Request Date

Final Request Received Date

Comments

1

03/04/13 E-mail

2

03/04/13 E-mail

03/04/13 E-mail

a.

03/04/13 E-mail

b.

03/04/13 E-mail

c.

03/04/13 E-mail

d.

03/04/13 E-mail

e.

03/04/13 E-mail

f.03/04/13 E-mail

g.

03/04/13 E-mail

4

03/04/13 E-mail

Menu #9- Immunization Registries Data Submission: The exclusion was claimed for this measure. Either a statement attesting to the fact that no immunizations were administered or a letter/e-mail from the immunization registry stating that they were unable to receive immunization data electronically at the time of your attestation.

For the Core Measures listed on tab (2) of this workbook, the documentation supplied for numerators and denominators does not agree to what was reported on your attestation. Could you please explain these variances?

3

Core #15- Protect Electronic Health Information: Proof that a security risk analysis of the certified EHR technology was performed prior to the end of the reporting period (i.e. report which documents the procedures performed during the analysis, the results of the analysis, and whether corrective measures were implemented as necessary).

Menu #1- Drug Formulary Checks: An audit trail from the EHR software which demonstrates that the drug formulary functionality was enabled for the entire attestation period.

Core #11- Clinical Decision Support Rule: An audit trail from the EHR software which demonstrates that a clinical decision support rule was enabled for the entire attestation period.

Core #14- Electronic Exchange of Clinical Information: Screenshots from the EHR which document a test exchange of key clinical information or a letter/e-mail from the receiving provider confirming the electronic exchange. This documentation should include the date of the exchange, the names of the sending/receiving providers, the type of EHR used by each provider, and whether the exchange was successful or unsuccessful.

Menu #3- Patient Lists: A list of your patients sorted by a specific medical condition that was generated by the EHR.

(B)Requested Documents

Proof of Possession- Please provide licensing agreements, invoices, contracts, etc. from the time the EHR technology system was purchased and/or updated. Ensure that the vendor, product name AND product version number that was attested to is included on the documentation.

Core #2- Drug Interaction Checks: An audit trail from the EHR software which demonstrates that the drug interaction functionality was enabled for the entire attestation period.

Please provide all of the documents requested below by the due date. The auditor will complete Column C.

Reports were supplied which detail the numerators and denominators of the Core Measures. However, we did not receive reports for the Menu Measures. Please supply a summary report for your attestation period (1/3/11 - 4/4/11) for the following measures:

Menu #2 - Clinical Lab Test ResultsMenu #7 - Medication Reconciliation

(C)For Completion by Auditor

No documentation was supplied to support the following “Yes”/”No" attestation measures: Core #2- Drug Interaction Checks, Core #11- Clinical Decision Support Rule, Core #14- Electronic Exchange of Clinical Information, Core #15- Protect Electronic Health Information, Menu #1- Drug Formulary Checks, Menu #3- Patient Lists, Menu #9- Immunization registries Data Submission. Please supply documentation to support these measures. Please see the following examples of what may be supplied for each measure:

Centers for Medicare and Medicaid ServicesDocument Request List - Eligible Professionals

Medicare Electronic Health Record (EHR) Incentive Program

Dr. Matthew Bliven

30000001SW7XEAS

1/3/2011-4/4/2011

Organization:

EHR Certification Number:

EHR Reporting Period:

16

Page 17: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Survival Mode

Don’t panic

Work with your EHR and other supporting vendors

Focus specifically on what is requested – no more and no less

Detail is good

17

Page 18: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Survival Mode

Dates are critical – make sure you can document what you attested to occurred during the attestation period

It will be fine (if you’re able to demonstrate you met the requirements)

May require multiple iterations

Work with all your EMR Partners – State RegistryCounty Health DepartmentHIT Regional Extension Center

18

Page 19: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Pitfalls to Avoid

Reports, screen prints, letters from vendors related to MU, etc. must be dated during the attestation period

If you attested to something you didn’t do (like conduct that risk analysis), you will likely be asked to pay the money back

You can’t respond timely if you don’t know where your documentation is

19

Page 20: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Pitfalls to Avoid

Keep your EHR vendor honest – just because they were certified doesn’t mean everything works, especially if you customize

If your EHR vendor can’t produce the exact data from the attestation period, you may be asked to return the incentive payment

Make sure you can produce proof if something changed and why

20

Page 21: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Example of Vendor Failure

EHR miscounted number of encounters – cancelled appointments were tallied

Data stored in EHR was cumulative – the data from the attestation period wasn’t preserved

Manual count of encounters did not match EHR reports

All measures were met but due to EHR issues, the provider was asked to return the incentive

21

Page 22: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Pitfalls to AvoidIf using multiple vendors for MU, make sure you

can consolidate the data

Make sure all dates and data from each vendor matches

Specialty practices beware – modifications to meet needs may make proving you did the right thing difficult

Make sure you have the right EHR version – some vendors offer certified and non-certified EHRs

22

Page 23: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Pitfalls to Avoid

If you’re just starting, do plenty of research

Make sure what you’re buying is the certified version (not the basic and after install the vendor asks for more money)

Auditors are black and white but have been reasonable thus far

Train you staff – what to say and not to say to an auditor

23

Page 24: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

How to Prepare

Before the auditor arrives:Run through a mock auditTalk to your colleagues who have

been auditedTalk to your vendorsPreserve data just in case your

vendor fails you

24

Page 25: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

How to Prepare

Take a close look at each measure you attested to and generate proof you met the measure

Save that documentation centrally

Don’t forget it’s more than conducting a risk analysis – remember the risk mitigation and management part

Make sure that patient portal is up, operable and used (available to 50% of patients and 5% are using)

25

Page 26: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

How to Prepare

Can your patients communicate with you securely and are they doing so?

Omnibus Rule permits unencrypted communication with patients but MU does not

When sending or providing required information like summaries of care, make sure it’s documented somewhere (paper and electronic)

26

Page 27: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

How to Prepare

If you use an HIE to exchange data that needs to be counted, such as a summary of care, make sure it can be tracked

Don’t lose sight of other privacy and security requirements – lack of attention may result in an OCR letter

Don’t trust vendors – make them prove it

27

Page 28: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Reasons Not to Attest

Not all health care professionals are eligible

It doesn’t pencil outLow or no Medicare patient countCost and burden are considered excessiveYou don’t think you can meet measures

during attestation period

28

Page 29: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

In The End…

You need to be able to prove it

CMS will ask for its money back

States and Medicaid incentive program audits still a mystery

Most auditors don’t have a sense of humor

If you have it, make sure you can find it and quickly

29

Page 31: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Resources

CMS Stage 1 Attestation Worksheet (hospitals): http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/downloads/Hospital_Attestation_Worksheet.pdf

CMS Meaningful Use for Specialists Tips: http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Downloads/Meaningful_Use_Specialists_Tipsheet_1_7_2013.pdf

31

Page 32: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Resources

CMS Meaningful Use Rule Change – 2014: http://www.cms.gov/Newsroom/MediaReleaseDatabase/Press-releases/2014-Press-releases-items/2014-08-29.html

NJ-HITECH “Become Audit Proof”: http://www.njhitec.org/files/6113/6803/5394/Become_Audit_Proof.pdf

31

Page 33: Meaningful Use, MU Audits and Stage 2 Measures – “Is it Worth the Money?” Chris Apgar, CISSP OrHIMA Fall Instutute 2014

Chris Apgar, CISSPCEO & President